-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, MJU0Jj15Mr11PxWla3P845Og/EyNu0lg4/DL0sQVh0UW6w0PdAsk8QzciBLKH9Rk htQ2j24JmVAtm1bI/JSUdw== 0000105770-08-000012.txt : 20080222 0000105770-08-000012.hdr.sgml : 20080222 20080222110411 ACCESSION NUMBER: 0000105770-08-000012 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20080221 ITEM INFORMATION: Entry into a Material Definitive Agreement FILED AS OF DATE: 20080222 DATE AS OF CHANGE: 20080222 FILER: COMPANY DATA: COMPANY CONFORMED NAME: WEST PHARMACEUTICAL SERVICES INC CENTRAL INDEX KEY: 0000105770 STANDARD INDUSTRIAL CLASSIFICATION: FABRICATED RUBBER PRODUCTS, NEC [3060] IRS NUMBER: 231210010 STATE OF INCORPORATION: PA FISCAL YEAR END: 1207 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-08036 FILM NUMBER: 08635076 BUSINESS ADDRESS: STREET 1: 101 GORDON DR STREET 2: P O BOX 645 CITY: LIONVILLE STATE: PA ZIP: 19341-0645 BUSINESS PHONE: 6105942900 MAIL ADDRESS: STREET 1: 101 GORDON DRIVE STREET 2: PO BOX 645 CITY: LIONVILLE STATE: PA ZIP: 19341-0645 FORMER COMPANY: FORMER CONFORMED NAME: WEST CO INC DATE OF NAME CHANGE: 19990405 8-K 1 file8k.htm FILE 8K SUPPLY AGREEMENT BD

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

________________

 

CURRENT REPORT

 

PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of Earliest Event Reported) – February 15, 2008

 

________________________

 

WEST PHARMACEUTICAL SERVICES, INC.

.

(Exact name of registrant as specified in its charter)

 

_____________________

 

 

 

 

Pennsylvania

1-8036

23-1210010

(State or other jurisdiction
of incorporation)

(Commission File Number)

(IRS Employer

Identification No.)

 

 

 

101 Gordon Drive, PO Box 645, Lionville, PA

 

19341-0645

(Address of principal executive offices)

 

(Zip Code)

 

610-594-3319

(Registrant’s telephone number, including area code)

 

Not Applicable

(Former name or address, if changed since last report)

____________________

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

o

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

o

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

o

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

o

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Item 1.01

Entry into a Material Definitive Agreement.

 

 

On February 15, 2008, West Pharmaceutical Services, Inc. (“West”) entered into a supply contract with Becton, Dickinson and Company (“BD”), which covers substantially all of West’s products currently being sold to BD.™ (1) BD is West’s largest customer.

 

The agreement contains fixed pricing over the term of the contract for West products, with rebates and penalties on certain products based on the increase or decrease, respectively, of annual sales volumes. The agreement contains a mechanism for adjusting prices annually based on changes in a U.S. Producer Price Index that tracks synthetic elastomers.

 

 

The agreement is made effective as of October 1, 2007 and will expire on September 30, 2012. It replaces a similar three-year contract that expired on September 30, 2007.

 

(1) BD is a trademark of Becton, Dickinson and Company.

 

 

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

WEST PHARMACEUTICAL SERVICES, INC.

 

/s/ John R. Gailey III

John R. Gailey III

Vice President, General Counsel and Secretary

 

February 22, 2008

 

 

 

 -----END PRIVACY-ENHANCED MESSAGE-----